- Presentations
- 6
- Markets
- 1
Xpovio is a brand of Selinexor marketed by Karyopharm Therapeutics, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Selinexor
- Brand owner
- Karyopharm Therapeutics
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 20 mg tablet, 40 mg tablet, 50 mg tablet, 60 mg tablet, 80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xpovio 10 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
| Xpovio 20 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
| Xpovio 40 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
| Xpovio 50 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
| Xpovio 60 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
| Xpovio 80 mg tabletOral | Karyopharm Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xpovio
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.